Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
470.60    0.60 (0.13%)
Bid:
469.80
Ask:
470.20
Spread: 0.40 (0.085%)
Market Cap: £2.43b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

QinetiQ Group plc Third Quarter Trading Update

21 Jan 2025 07:00

RNS Number : 0194U
QinetiQ Group plc
21 January 2025
 

News release

QinetiQ Group plc

Third Quarter Trading Update

21 January 2025 - QinetiQ Group plc ("QinetiQ" or the "Group") today issues a trading update covering the third quarter.

Full year and mid-term expectations unchanged

In line with our guidance, for the full year we continue to expect to deliver high single digit organic revenue growth at stable underlying margin with high cash conversion and in the mid-term £2.4bn of organic revenue at c.12% margin by 2027. Our £100m share buyback programme is on-track to complete in early February and on completion we will commence the additional £50m share buyback programme announced at our Interim Results.

Trading environment

We have continued to deliver revenue growth in EMEA Services, where good visibility in the medium term has not changed and the opportunity set of major programmes is strong as outlined at the Interim Results presentation. Short-term order intake in the UK has been slower than expected due to the fiscal environment and we have taken proactive action to resize some of our capabilities in our UK Intelligence business. Our UK Defence business which has greater exposure to longer duration contracts has remained strong.

Order intake remains robust with stable revenue in Global Solutions, despite headwinds in the contracting environment in the US. We are pleased to announce that Tom Vecchiolla has taken over the leadership of our US business, succeeding Shawn Purvis who helped build the business and brand in the US. Tom is a highly experienced and seasoned leader having been President of Raytheon International Inc. and most recently CEO of ST Engineering North America.

With increasing spending over the long-term in our core markets and our capabilities aligned to the evolving threat environment, we continue to secure a number of highly relevant and strategic programmes. Order intake is in line with last year at £1.3bn and notable achievements in the quarter include opening a new forward operating base in Huntsville, Alabama to support our new US Army Aerial Target Systems 3 (ATS-3) contract, supporting the rapid entry into service of the new Archer self-propelled 155 mm howitzer for the British Army through our high value Test and Evaluation services and securing a strategic partner contract in Australia for Engineering Services worth more than $50m over 5 years.

Steve Wadey, Group Chief Executive Officer said:

"Our expectations for the full year remain unchanged, thanks to the hard work of our talented people who have continued to focus on consistent operational delivery across the Group.

"I am confident that QinetiQ remains well positioned to deliver long-term growth and value creation for shareholders, with highly relevant and differentiated capabilities, an established presence across key growth markets and an orders pipeline worth over £11bn giving us significant long-term visibility."

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

For further information please contact:

Stephen Lamacraft, Group Interim Director Investor Relations: +44 (0) 7471 885817

Lindsay Walls, Group Director Communications (Media enquiries) +44 (0) 7793 427582

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLDLRIIFIE
Date   Source Headline
2nd Jun 20266:00 pmRNSHolding(s) in Company
2nd Jun 20267:00 amRNSTransaction in Own Shares
29th May 20264:45 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSQinetiQ Full Year Results 2026
20th May 20264:16 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20264:57 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20269:46 amRNSTransaction in Own Shares
30th Apr 20263:10 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20261:38 pmRNSDirector Declaration
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 202610:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20263:01 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 202611:39 amRNSHolding(s) in Company
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20263:30 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.